The anti-anginal drug that’s used in type 2 diabetes patients has shown more positive effects in those who have a poorer glucose control, so say the American College of Cardiology. Ranolazine is used to treat chronic angina and chest pains, but it has been discovered that this drug could help diabetes sufferer’s deal with chest pains, as well as those dealing with coronary heart disease. It’s an uncommon truth that those suffering with diabetes are more at risk of developing coronary heart disease, which leads to more chest pains and angina.
Angina is linked to an increased risk of hospitalisation, in addition to costly medications and a worse quality of life. It is more common in those dealing with diabetes, a lifestyle-related condition which affects millions of people and is on the rise due to today’s unhealthy combination of less exercise and a high fat diet. Those who are overweight are at risk, as are people who eat a lot of sugar or fat in their diet. If you think you may have the symptoms of diabetes, you should aim to increase your exercise and eat a more balanced diet that’s rich in fruit and vegetables. It’s advised that you speak to your GP as well, so that they can offer the right treatment if need be.
Researchers found that Ranolazine helped to reduce the chest pain in people with poor glucose control, showing that diabetes patients could see a benefit with their symptoms. Further studies need to take place in order to categorically prove that this drug could work, but researchers are hopeful that this could be a route healthcare professionals could take in future. Though studies have been carried out to prove its effectiveness with angina, this is the first trial of its kind in regards to diabetes.
Comments are closed.